2020 – Our First Virtual Annual Meeting!
Our first ever virtual meeting was an enormous success thanks to the patience and diligence of our speakers and presenters. We have posted several of the winning paper presentations and keynote presentations from this meeting on this page for you to watch if you were not able to join us or revisit if you were. There is also a full list of all winning papers.
The Exhibitor Center will remain open until October 2021 so please stop by and visit our industry partners.
We plan to return to the Trumbull Marriott on Friday, 08 October 2021. The Chapter thanks our friends at the Marriott for being so gracious to us this year.
3M, with newly-acquired KCI, focuses on providing better care through patient-centered science. Helping transform patient outcomes by reducing the risk of preventable complications. From solutions for BSI and SSI risk reduction to vital sign monitoring and temperature management, our team is ready to partner with you to strive toward a world with zero complications.
3m.com/skinandnasal www.bairhugger.com 3m.com/medical
Prevena(tm) Incision Management Evidence Brochure
PREVENA RESTOR BELLA*FORM(tm) Incision Management System
PREVENA RESTOR ARTHRO*FORM(tm) Incision Management System
V.A.C. VERAFLO(tm) Therapy & DERMATAC(tm) Drape Brochure
Good is no longer good enough or VERAFLO(tm) Therapy
Abbott is the leading global healthcare company that helps people live better and healthier lives through life-changing technology and nutrition products like the Ensure Surgery and Pre Surgery.
Perioperative nutrition can help reduce surgical site infections, decrease complications, shorten length of stay and decrease cost of care. Abbott Nutrition has developed products specially designed to help individuals prepare for, and recover from, major surgery. The Ensure Perioperative supplements include a clear liquid preoperative carbohydrate drink (Ensure Pre Surgery) and an Immunonutrition Shake (Ensure Surgery).
Ensure Pre Surgery:
- Recommendation: Drink 2 bottles the day before surgery, and 1 bottle up to 2 hours prior to surgery
- Designed to help reduce insulin resistance after surgery and improve patient outcomes
- Designed to be consumed up to 2 hours before surgery
- Has a recommended dose of carbohydrates (50 g maltodextrin per serving), as indicated by ERAS guidelines, compared to regular sports drinks, which contain approximately 21 g per 12-fl-oz serving
- Meets ERAS guidelines for pre-surgery use of a clear carbohydrate beverage
- Meets American Society of Anesthesiologists (ASA®) guidelines for use with preoperative fasting
- Recommendation: Drink 2 or 3 shakes per day, 5-7 days pre and post surgery
- Designed to support immune health and recovery from surgery
- Contains 1.1 g EPA & DHA (omega-3 fatty acids from fish oil) and 4.2 g arginine per 8 fl oz to support immune health and surgical recovery
- High in protein (18 g / serving, 21% of kcals) to support protein synthesis, tissue repair, and wound healing
- Designed to support your distinct nutritional needs before and after surgery with a specialized blend of immune-modulating ingredients
- Contains an excellent source of vitamin D
- Contains the antioxidants selenium, and vitamins C & E
Help set your patients up for success. Reach out to your local Abbott Nutrition Representative to learn more about how to get your patients access to the perioperative nutrition that will support their enhanced recovery after surgery.
Ensure Perioperative Nutrition Supplements
Ethicon US LLC , a Johnson & Johnson company, commercializes a broad range of innovative surgical products, solutions and technologies used to treat some of today’s most prevalent medical issues, such as: colorectal and thoracic conditions, women’s health conditions, hernias, cancer and obesity.
Learn more at www.ethicon.com, or follow us on Twitter @Ethicon.
ECHELON ENDOPATH™ Staple Line Reinforcement (click for brochure)
Ethicon is excited to introduce our new Virtual Exhibit Booth – Check it out!
VISTASEAL in Cardiovascular Surgery
Gore engineers medical devices that treat a range of cardiovascular and other health conditions. With more than 45 million medical devices implanted over the course of more than 40 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives.
At Irrimax, our focus is simple – to reduce infections along with healthcare costs, allowing healthcare providers to make improving patient outcomes, priority number #1. The company’s flagship product, Irrisept®, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.
Irrimax Corporation has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Our management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.
Please visit www.irrisept.com for more information.
Please click images to download more information
Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together.
Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value — for healthcare systems, providers, and the people they serve. Learn more at Medtronic.com.
For more information on any of the products or services offered by Medtronic, please contact your local sales representative or email
Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.
For more information on EXPAREL, please visit www.EXPAREL.com
For information to share with your patients, please visit: www.EXPAREL.com/toolkit
To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com
Sonosite PX ultrasound machine presents a new world where point-of-care ultrasound is a tool no longer – but rather a partner for clinicians.
Visit the Sonosite PX Showcase today!
(click for brochure)
Please enjoy these presentations from our 2020 Annual Meeting
Welcome Address - Alan Meinke, MD. FACS
Presidential Address - Alan Meinke, MD, FACS
Foster Lecture "Tackling Surgical QI Challenges: Frameworks and Fundamentals" - Joe "Pat" Patton, MD, FACS
John MacArthur, MD, FACS Trauma Competition - 2nd Place - Meaghan Broderick MD - Utility of Repeat Head Ct In Detecting Delayed Intracranial Hemorrhage In Falls On Novel Oral Anticoagulants
Surgical Quality, NSQIP and ERAS Competition - 1st place - Brienne Ryan MD - The Effects of a Preoperative Optimization Program on Surgical Cancellation Rates
Medical Students Competition -1st Place - Jennifer Hansen, MHS - Region, Size, and Teaching-Status: Identifying Hospital-Level Factors that Impact Surgery Unit Patient Safety Culture
Sultan Ahamed, MD, FACS General Surgery Competition - 2nd place - Georgios Mihalopulos MD - Foramen of Winslow Hernia: A Rare Cause of Bowel Obstruction
Surgical Subspecialties Competition - 1st Place - Brittany Davis MD - Surgical Treatment of the Neurogenic Etiology of Median Arcuate Ligament
2020 Paper Competition Winners
|John MacArthur Trauma Competition 1st||Santosh Swaminathan, MD||Saint Mary's Hospital||Use of Engineered Exosomes Isolated from Thioredoxin-1 Overexpressed Mice Subjected to Cecal Ligation and Puncture Leads to Prolonged Survival following Severe Sepsis
|John MacArthur Trauma Competition 2nd||Meaghan Broderick MD||Stamford Hospital||Utility of Repeat Head Ct In Detecting Delayed Intracranial Hemorrhage In Falls On Novel Oral Anticoagulants
|Surgical Quality, NSQIP & ERAS 1st||Brienne Ryan MD||Stamford Hospital||The Effects of a Preoperative Optimization Program on Surgical Cancellation Rates
|Surgical Quality, NSQIP & ERAS 2nd||Santosh Swaminathan MD||Saint Mary's Hospital||Outcomes Following Elective Minimally Invasive Bariatric Surgery in High Risk Patients: A MBSAQIP Analysis
|Medical Students 1st||Jennifer Hansen, MHS||Frank H Netter MD School of Medicine - QU||Region, Size, and Teaching-Status: Identifying Hospital-Level Factors that Impact Surgery Unit Patient Safety Culture
|Sultan Ahamed General Surgery 1st||Santosh Swaminathan, MD||Saint Mary's Hospital||Overexpression of Pellino-1 in Cardiomyocytes Limits Systemic Inflammation, Cardiac Cell Death and Preserves Cardiac Function in a Murine Sepsis Model
|Sultan Ahamed General Surgery 2nd||Georgios Mihalopulos MD||Waterbury Hospital||Foramen of Winslow Hernia: A Rare Cause of Bowel Obstruction
|Surgical Subspecialties 1st||Brittany Davis MD||Stamford Hospital||Surgical Treatment of the Neurogenic Etiology of Median Arcuate Ligament
|Surgical Subspecialties 2nd||Diego Accorsi, MD||Saint Mary's Hospital||Thioredoxin-1 Engineered Exosomes are a Promising Strategy to Stimulate Angiogenesis and Increase Blood Flow in a Murine Model of Hind Limb Ischemia